Ruthenium(II) cis-triaminocyclohexane complexes as anti-cancer compounds
Ruthenium complexes are promising candidates for the treatment of cancers. Two ruthenium(III) complexes have previously completed phase I clinical trials and half-sandwich ruthenium(II) η6-arene complexes are receiving much interest as anti-cancer agents. A range of new ruthenium(II) complexes have...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of York
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.561061 |